Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach.

Abstract

The vast majority of adults with acute lymphoblastic leukemia (ALL) now achieve remission with current intensive chemotherapy regimens. Nevertheless, most adults with ALL will eventually relapse and die of their disease. Specific clinical and molecular-cytogenetic prognostic factors have been identified that are beginning to provide insights for the… (More)

Topics

Cite this paper

@article{Verma2001ManagementOA, title={Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach.}, author={A. Verma and Wendy A. Stock}, journal={Current opinion in oncology}, year={2001}, volume={13 1}, pages={14-20} }